Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
FIGO 2023 staging for endometrial cancer, when, if it is not now?
FIGO 2023 staging for endometrial cancer, when, if it is not now? European journal of cancer (Oxford, England : 1990) Matias-Guiu, X., Lax, S., Raspollini, M. R., Palacios, J., Zheng, W., Liu, C., de Brot, L., Lordello, L., Hardisson, D., Gaffney, D., Mutch, D., Scambia, G., Creutzberg, C. L., Fotopoulou, C., Berek, J. S., Concin, N. 2024; 213: 115115Abstract
Incorporation of pathological and (not mandatory) molecular features into the new FIGO 2023 staging system has generated some controversy. Several validations have been published recently that demonstrated the higher prognostic precision of FIGO 2023 compared to the previous FIGO 2009 scheme. In the present article, the authors want to respond to some concerns that were raised by some pathologists and clinicians.
View details for DOI 10.1016/j.ejca.2024.115115
View details for PubMedID 39520836